Recently, Eli Lilly and Company (“Lilly”) launched an innovative pilot program to monitor the production of insulin pens, including assembly, injection molds and other equipment used to produce the pens. Production takes place at contract manufacturers (CMs) and Original Equipment Manufacturers (OEMs), and the OSIsoft PI System with PI Cloud Connect is being used to gather data to identify areas of improvement in the production process and machinery. As Brian Goldinger, Manufacturing IT Consultant at Eli Lilly, explained at the 2017 OSIsoft Users Conference in San Francisco, the real-time visibility enabled by the PI System will potentially allow Lilly to not only reduce manual data collection, the new process can elevate OEM/CM performance and allow the brand to scale production while maintaining its high standards of quality.